Ani Pharmaceuticals (ANIP) Current Assets (2010 - 2026)
Ani Pharmaceuticals (ANIP) posted Current Assets of $747.1 million for Q1 2026, down 0.8% sequentially from $753.1 million in Q4 2025, and up 39.31% YoY from $536.3 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Current Assets (2010 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Current Assets for 17 years, with the latest figure at $747.1 million in Q1 2026.
- Quarterly Current Assets rose 39.31% year-over-year to $747.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $747.1 million (up 39.31% YoY) and the FY2025 annual result came in at $753.1 million, up 42.51% from the prior year.
- Current Assets declined to $747.1 million in Q1 2026 per ANIP's latest filing, from $753.1 million in the prior quarter.
- Over five years, Current Assets peaked at $753.1 million in Q4 2025 and troughed at $301.4 million in Q1 2022.
- A 5-year average of $506.0 million and a median of $521.3 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 68.09% in 2022, then fell 0.79% in 2025.
- Over 5 years, Current Assets stood at $344.3 million in 2022, then jumped by 50.99% to $519.8 million in 2023, then climbed by 1.66% to $528.5 million in 2024, then jumped by 42.51% to $753.1 million in 2025, then slipped by 0.8% to $747.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $747.1 million, $753.1 million, and $698.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn | 825.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 825.43 Mn |
| Mar 31, 2026 | 747.08 Mn |
| Dec 31, 2025 | 753.12 Mn |
| Sep 30, 2025 | 698.40 Mn |
| Jun 30, 2025 | 602.63 Mn |
| Mar 31, 2025 | 536.29 Mn |
| Dec 31, 2024 | 528.46 Mn |
| Sep 30, 2024 | 521.30 Mn |
| Jun 30, 2024 | 555.46 Mn |
| Mar 31, 2024 | 540.56 Mn |
| Dec 31, 2023 | 519.82 Mn |
| Sep 30, 2023 | 497.22 Mn |
| Jun 30, 2023 | 459.31 Mn |
| Mar 31, 2023 | 364.75 Mn |
| Dec 31, 2022 | 344.26 Mn |
| Sep 30, 2022 | 309.38 Mn |
| Jun 30, 2022 | 322.40 Mn |
| Mar 31, 2022 | 301.40 Mn |
| Dec 31, 2021 | 321.78 Mn |
| Sep 30, 2021 | 191.38 Mn |